Table 2.
The prevalence of DR, DME and VTDR in different groups of the obesity-related indexes
| No of patients | DR prevalence, % | DME prevalence, % | VTDR prevalence, % | |
| BMI, kg/m2 (n=2245) | ||||
| 18.5–22.9 (normal weight) | 683 | 14.20 | 4.25 | 4.54 |
| 23.0–25.0 (over weight) | 615 | 17.24 | 4.88 | 5.37 |
| ≥25.0 (obese) | 947 | 12.99 | 2.96 | 2.96 |
| WHR, (n=483) | ||||
| Quarter 1 | 124 | 13.71 | 2.42 | 3.23 |
| Quarter 2 | 117 | 17.95 | 5.13 | 5.13 |
| Quarter 3 | 121 | 11.57 | 1.65 | 2.48 |
| Quarter 4 | 121 | 25.62 | 8.26 | 8.26 |
| WHtR, (n=1484) | ||||
| Quarter 1 | 371 | 16.17 | 5.12 | 5.39 |
| Quarter 2 | 373 | 16.09 | 5.90 | 6.17 |
| Quarter 3 | 369 | 14.09 | 4.07 | 4.07 |
| Quarter 4 | 371 | 14.29 | 1.89 | 1.89 |
| BAI, (n=483) | ||||
| Quarter 1 | 121 | 26.45 | 7.44 | 8.26 |
| Quarter 2 | 121 | 17.36 | 4.13 | 4.13 |
| Quarter 3 | 121 | 12.40 | 4.13 | 4.13 |
| Quarter 4 | 120 | 14.17 | 1.67 | 2.50 |
BAI, Body Adiposity Index; BMI, body mass index; DME, diabetic macular oedema; DR, diabetic retinopathy; VTDR, vision-threatening diabetic retinopathy; WHR, waist to hip ratio; WHtR, waist to height ratio.